Shiro Watanabe

13PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Infant and child healthEpidemiological modellingSolid tumoursRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 23, 2026
Somatostatin receptor expression for peptide receptor radionuclide therapy in Japanese patients with recurrent or metastatic differentiated thyroid cancer.

Shiro Watanabe, Kenji Hirata, Junki Takenaka

|Dec 09, 2025
Unexpected [ 18 F] Fluciclovine Uptake in Pilocytic Astrocytoma: A Pediatric Case Report.

Hiroto Koga, Shiro Watanabe, Kenji Hirata

|Sep 12, 2025
Association between FDG accumulation in interstitial lesions and acute exacerbation risk in lung cancer: multicenter analysis.

Yuriko Ishida, Shiro Watanabe, Jun Sakakibara-Konishi

|Jun 13, 2025
The Biochemical-Imaging Connection: Urinary Noradrenaline and Fluorodeoxyglucose-Positron Emission Tomography in Unresectable or Metastatic Pheochromocytomas and Paragangliomas.

Junki Takenaka, Shiro Watanabe, Takashige Abe

|Apr 05, 2025
Factors and predictors affecting late external dose rates and isolation period in patients after lutetium-177-labeled DOTA-Tyr3-octreotate treatment for neuroendocrine tumors.

Naoto Wakabayashi, Shiro Watanabe, Satoshi Takeuchi

|Feb 26, 2025
Urinary Dopamine Levels Can Predict the Avidity of Post-Therapy [131I]MIBG Scintigraphy in Unresectable or Metastatic Pheochromocytomas and Paragangliomas: A Preliminary Clinical Study.

Junki Takenaka, Shiro Watanabe, Takashige Abe

Pageof 3

Frequent Collaborators

4 joint publications

Kenji Hirata

2 joint publications

Kohsuke Kudo

2 joint publications

Naoto Wakabayashi

2 joint publications

Satoshi Takeuchi